Docoh
Loading...

KRMD Repro-Med Systems

Filed: 19 May 21, 4:24pm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported)   May 18, 2021

 

REPRO MED SYSTEMS, INC.

(Exact name of registrant as specified in its charter)

 

New York

0-12305

13-3044880

(State or other jurisdiction
of incorporation)

(Commission
File Number)

(IRS Employer
Identification No.)


24 Carpenter Road, Chester, New York

10918

(Address of principal executive offices)

(Zip Code)


Registrant’s telephone number, including area code   (845) 469-2042

 

not applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading symbol(s)

Name of each exchange on which registered

common stock, $0.01 par value

KRMD

The Nasdaq Stock Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company  [_]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  [_]

 



ITEM 5.07  SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS


Set forth below are the voting results from the 2021 Annual Meeting of Shareholders held on May 18, 2021:


PROPOSAL 1:  ELECTION OF DIRECTORS


The nominees for director set forth under “Nominees” below were elected to the Company’s board of directors.


 

NUMBER OF SHARES

NOMINEES

FOR

WITHHELD

BROKER
NON-VOTE

Daniel S. Goldberger

23,246,142

244,194

9,045,943

R. John Fletcher

23,224,906

265,430

9,045,943

David W. Anderson

23,292,196

198,140

9,045,943

Joseph M. Manko, Jr.

23,156,266

334,070

9,045,943

Robert T. Allen

23,245,165

245,171

9,045,943

James M. Beck

23,321,586

168,750

9,045,943

Kathy S. Frommer

23,287,178

203,158

9,045,943

Donna French

23,328,169

162,167

9,045,943

Shahriar (Shar) Matin

23,316,113

174,223

9,045,943


PROPOSAL 2:  ADVISORY VOTE - EXECUTIVE COMPENSATION


The Company’s shareholders approved, on an advisory basis, the compensation of the Company’s executive officers.


 

FOR

AGAINST

ABSTAIN

BROKER
NON-VOTE

Number of Shares

23,151,539

241,504

97,293

9,045,943


PROPOSAL 3:  RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTANTS


The Company’s shareholders ratified the appointment of McGrail Merkel Quinn & Associates, P.C. as the Company’s independent registered public accountants for the 2021 fiscal year.


 

FOR

AGAINST

ABSTAIN

Number of Shares

32,347,229

121,635

67,415


PROPOSAL 4:  APPROVAL OF EQUITY PLAN


The Company’s shareholders approved the Company’s 2021 Omnibus Equity Incentive Plan.


 

FOR

AGAINST

ABSTAIN

BROKER
NON-VOTE

Number of Shares

23,112,906

290,882

86,548

9,045,943


- 2 -



SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


 

REPRO MED SYSTEMS, INC.
(Registrant)

 

 

 

Date:  May 19, 2021

By:

/s/ Karen Fisher

 

Karen Fisher
Chief Financial Officer

 

- 3 -